Drawing for IONOJET

USPTO serial 88342025

IONOJET

Reviewed by CopyMark Law Group

Reg. 6885177Status 700Registered
Filing date
Status date
Registration date
Oct 25, 2022
Examiner
PAINTER, VALERIYA SHERMAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with IONOJET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karen Feisthamel

Karen Feisthamel KDB Firm PLLC2601 Weston Parkway, Suite 103Cary, NC 27513UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Therapeutic pharmaceutical for the treatment of damaged skin and tissue; Therapeutic pharmaceutical for the treatment of infectious diseases, pain, inflammation, sepsis, obesity and cognitive disorders; Therapeutic pharmaceutical for the treatment of viral metabolic endocrine musculoskeletal cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, psychiatric, and immune system related disease and disorders; Therapeutic pharmaceutical for the treatment of pulmonary hypertension via inhalation; Therapeutic pharmaceutical for the treatment of ocular disorders or diseases, bacteria based diseases, diabetes related complications, anti-infective preparations, antiviral preparations, antibiotics, and vaccines; Therapeutic pharmaceutical for the treatment of tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Therapeutic pharmaceutical for the treatment of woundsACTIVEFeb 28, 2022

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 13, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 25, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 25, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 20, 2022SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 17, 2022CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 25, 2022SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 23, 2022IUAFUSE AMENDMENT FILED—
Aug 23, 2022EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 2, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 1, 2022EX5GSOU EXTENSION 5 GRANTED—
Feb 23, 2022EXT5SOU EXTENSION 5 FILED—
Feb 23, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 28, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 26, 2021EX4GSOU EXTENSION 4 GRANTED—
Aug 26, 2021EXT4SOU EXTENSION 4 FILED—
Aug 26, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 26, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 26, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 26, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 26, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 24, 2021EX3GSOU EXTENSION 3 GRANTED—
Feb 24, 2021EXT3SOU EXTENSION 3 FILED—
Feb 24, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 26, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 24, 2020EX2GSOU EXTENSION 2 GRANTED—
Aug 24, 2020EXT2SOU EXTENSION 2 FILED—
Aug 24, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 23, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 22, 2020EX1GSOU EXTENSION 1 GRANTED—
Apr 22, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 5, 2020NREVNOTICE OF REVIVAL - E-MAILED—
Apr 3, 2020TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Apr 3, 2020PETGPETITION TO REVIVE-GRANTED—
Apr 3, 2020PROATEAS PETITION TO REVIVE RECEIVED—
Mar 30, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 30, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 27, 2020EXT1SOU EXTENSION 1 FILED—
Aug 27, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 2, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 2, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 12, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 24, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 24, 2019DOCKASSIGNED TO EXAMINER—
Apr 4, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 19, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance